Story
Anthropic IPO Filing Reveals Massive Compute Spending, Spotlighting Broadcom and NVIDIA

Artificial intelligence company Anthropic's initial public offering filing has pulled back the curtain on its massive spending plans for computing power, naming chipmakers Broadcom (AVGO) and NVIDIA (NVDA) as key beneficiaries. The prospectus outlines significant financial commitments to build out the infrastructure needed to train and operate its AI models, creating a substantial demand pipeline for semiconductor suppliers.
Broadcom's Direct Exposure and Entanglements
Broadcom emerges as a direct and deeply integrated partner, according to the filing. Anthropic is on track to become Broadcom's largest custom-chip customer next year, with a five-year commitment to lease $125.2 billion in Tensor Processing Unit (TPU) capacity.
This relationship involves complex financial arrangements that present both opportunity and risk for Broadcom:
- A consortium of banks including Bank of America, Blackstone, Citi, and Morgan Stanley are arranging $63 billion in financing for Anthropic to purchase Broadcom's AI chips and networking equipment.
- Broadcom itself has agreed to lend up to $42 billion toward Anthropic's TPU leasing commitment and is providing "residual value support" to the third-party lenders.
This dual role as both a critical supplier and a financial backer was flagged in the filing for creating "potential conflicts of interest." A payment default by Anthropic could expose Broadcom to significant financial risk due to its loan and support obligations.
NVIDIA's Broader Market Position
AdNVIDIA is positioned as a broader beneficiary of Anthropic's spending through its dominant role in the data center market. The filing details Anthropic's large-scale commitments to cloud providers, including $114.5 billion with Google, $110 billion with Amazon, and $44.9 billion with Microsoft.
A substantial portion of this hyperscaler spending is expected to flow toward merchant GPUs, reinforcing NVIDIA's market-leading position, according to one analysis cited in the report. However, the report also notes a growing trend toward custom silicon, such as Google's TPUs and Amazon's Trainium chips, an area where Broadcom is a key player.
Market Reaction and Investor Considerations
The market appears to be weighing the different risk profiles of the two chipmakers. In the three months leading up to the filing, NVIDIA's stock gained 9.92%, while Broadcom's fell 14.10%, based on figures from the October 26 market close. This divergence suggests investors may be pricing in NVIDIA's established market dominance while discounting Broadcom due to its complex and concentrated financial entanglement with Anthropic.
Anthropic’s own filing acknowledges the risks associated with its strategy, noting its massive compute commitments could result in costly, underutilized capacity if demand for its AI services falters. An analyst from Rothschild & Co. described the situation as a "concentrated bet" on a few AI companies generating enough revenue to sustain the vast capital expenditure, highlighting the potential exposure for suppliers if that growth fails to materialize.
Read next
More on Stocks
AirTrunk Secures A$4.25 Billion Green Loan for Sydney Data Center Expansion
The Blackstone-backed data center operator has obtained one of Australia's largest data center financings from a consortium of 32 banks to fund the growth of its SYD3 hyperscale campus.

Salesforce, Microsoft, Apple Gains Face Test From Fed, Earnings
Shares of Salesforce, Microsoft, and Apple have posted significant gains in recent months, but now face key tests from an upcoming Federal Reserve meeting, corporate earnings, and analyst scrutiny over strategic moves.

ZAI Stock Surges Over 9% in Rebound From Competition-Fueled Sell-Off
Shares of ZAI Co Ltd recovered sharply on Tuesday after a steep decline, as investors reassessed competitive threats in China's artificial intelligence sector. The rally was part of a broader recovery in Hong Kong-listed AI stocks.

CDC Deputy Director to Depart Amid Reported Disagreements on Vaccine Policy
Dr. Jennifer Shuford, the CDC's deputy director, is expected to leave the Trump administration following the midterm elections, The Washington Post reported. Her departure comes as the administration plans significant changes to childhood vaccination schedules.